FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs Aug 15, 2019 Life Science
Deciphera Pharmaceuticals Announces Positive Top-line Results from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors Aug 14, 2019 Life Science
Endologix Announces Exclusive Distributor Agreement with Boston Scientific for the Chinese Market Aug 10, 2019 Life Science
Nanjing King-Friend Acquires Majority Stake in US Generic Injectables Company for $95 Million Aug 9, 2019 Life Science
